A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition
- Nathan Bucay,
- Divya Bhagirath,
- Kirandeep Sekhon,
- Thao Yang,
- Shinichiro Fukuhara,
- Shahana Majid
- Department of Veterans Affairs,
- University of California at San Francisco
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>The most frequent alteration in the prostate oncogenome is loss of chromosome (chr) 8p21 that has been associated with loss of NKX3.1 homeobox gene. Chr8p21 deletions increase significantly with tumor grade and are associated with poor prognosis in prostate cancer (PCa), suggesting critical involvement of this region in tumor progression. Recent studies suggest that apart from NKX3.1, this region harbors alternative tumor suppressors that are yet undefined. We proposed a novel, paradigm shifting hypothesis that this locus is associated with a miRNA gene cluster-miR-3622a/b-that plays a crucial suppressive role in PCa. Here we demonstrate the crucial role of miR-3622a in prostate cancer epithelial-To-mesenchymal transition (EMT). MicroRNA expression profiling in microdissected human PCa clinical tissues showed that miR-3622a expression is widely downregulated and is significantly correlated with poor survival outcome and tumor progression. To understand the functional significance of miR-3622a, knockdown and overexpression was performed using non-Transformed prostate epithelial and PCa cell lines, respectively, followed by functional assays. Our data demonstrate that endogenous miR-3622a expression is vital to maintain the epithelial state of normal and untransformed prostate cells. miR-3622a expression inhibits EMT, progression and metastasis of PCa in vitro and in vivo. Further, we found that miR-3622a directly targets EMT effectors ZEB1 and SNAI2. In view of these data, we propose that frequent loss of miR-3622a at chr8p21 region leads to induction of EMT states that in turn, promotes PCa progression and metastasis. This study has potentially significant implications in the field of prostate cancer as it identifies an important miRNA component of a frequently lost chromosomal region with critical roles in prostate carcinogenesis which is a highly significant step towards understanding the mechanistic involvement of this locus. Also, our study indicates that miR-3622a is a novel PCa biomarker and potential drug target for developing therapeutic regimens against advanced PCa.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 1263-1274 (12 pages)Journal (Volume, Issue Number)
Cell Death and Differentiation (Volume 24, Issue 7)Publication milestones
- Published - 07/01/2017
Publication status
Published - 07/01/2017
ISSN
1350-9047Publication IDs
- Scopus: 85021317629
- PubMed: 28498363
Publication metrics
Metrics
SciVal
citations
17
Fractional count
2
Fractional count
0.13
Fractional count
14
Fractional count
0.88
Fractional count
2
Fractional count
1
SciVal
FWCI
1.20
SciVal
Author count
16
SciVal
Paper percentile
86
PlumX, opens in new tab
Captures
29
Citation count
36
Funding Details
National Cancer Institute at the NIH (Grant Number RO1CA177984 to SS; RO1CA138642
